Shattuck Labs (STTK) CMO Pandite Arundathy Sells 30,000 Shares

What Happened Pandite Arundathy N., Chief Medical Officer of Shattuck Labs (STTK), sold 30,000 shares on 2026-05-12 in an open-market transaction. The weighted average price was $6.61 per share, yielding proceeds of approximately $198,300. This was a sale (routine disposition), not a purchase or grant.

Key Details

• Transaction date: 2026-05-12; Form 4 filed: 2026-05-14 (appears timely, within the typical 2-business-day window).
• Shares sold: 30,000; weighted average price: $6.61; total proceeds ≈ $198,300.
• Price range: individual trades occurred between $6.41 and $7.03 (report lists weighted avg; reporting person can provide per-price breakdown on request).
• Footnote: Sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 2, 2026.
• Shares owned after the transaction: not specified in the information provided in this summary.

Context

• Sales made under an established 10b5-1 plan are pre-arranged and are commonly used by insiders to systematically sell shares; they do not, by themselves, indicate current insider sentiment.
• No options were exercised, no gifts or awards were reported, and no late filing was indicated in the provided data.